Drug recall D-0181-2020

Class II Completed reported Nov 13, 2019

Product

Dr. Reddy's Ranitidine Tablets, USP 75 mg, 60 count bottles, NDC 55111-131-60, (OTC)

Reason for recall

CGMP Deviations: Presence of NDMA impurity detected in product.

Lots and codes

Batch Numbers: All lots within expiry.

Recall details

Recalling firm
Dr. Reddy's Laboratories, Inc., Princeton, NJ
Quantity
N/A
Distribution
Product was distributed to major distributors throughout the United States who may have further distributed the product.
Type
Voluntary: Firm initiated
Recall initiated
October 1, 2019

Related products